These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24566681)

  • 1. Role of RASSF1A promoter methylation in the pathogenesis of hepatocellular carcinoma: a meta-analysis of 21 cohort studies.
    Li YS; Xie Q; Yang DY; Zheng Y
    Mol Biol Rep; 2014 Jun; 41(6):3925-33. PubMed ID: 24566681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant promoter methylation of RASSF1A gene may be correlated with colorectal carcinogenesis: a meta-analysis.
    Wang HL; Zhang Y; Liu P; Zhou PY
    Mol Biol Rep; 2014 Jun; 41(6):3991-9. PubMed ID: 24566684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter methylation of the RASSF1A gene may contribute to colorectal cancer susceptibility: a meta-analysis of cohort studies.
    Wang HL; Liu P; Zhou PY; Zhang Y
    Ann Hum Genet; 2014 May; 78(3):208-16. PubMed ID: 24621386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of RASSF1A promoter methylation in the pathogenesis of ovarian cancer: a meta-analysis.
    Si JG; Su YY; Han YH; Chen RH
    Genet Test Mol Biomarkers; 2014 Jun; 18(6):394-402. PubMed ID: 24665911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant promoter methylation of SOCS-1 gene may contribute to the pathogenesis of hepatocellular carcinoma: a meta-analysis.
    Zhao RC; Zhou J; He JY; Wei YG; Qin Y; Li B
    J BUON; 2016; 21(1):142-51. PubMed ID: 27061542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of RASSF1A hypermethylation with risk of HBV/HCV-induced hepatocellular carcinoma: A meta-analysis.
    Peng JL; Wu JZ; Li GJ; Wu JL; Xi YM; Li XQ; Wang L
    Pathol Res Pract; 2020 Oct; 216(10):153099. PubMed ID: 32853942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter methylation of p16 and RASSF1A genes may contribute to the risk of papillary thyroid cancer: A meta-analysis.
    Jiang JL; Tian GL; Chen SJ; Xu LI; Wang HQ
    Exp Ther Med; 2015 Oct; 10(4):1549-1555. PubMed ID: 26622524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant promoter methylation of HIN-1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis.
    Dai D; Dong XH; Cheng ST; Zhu G; Guo XL
    Tumour Biol; 2014 Aug; 35(8):8209-16. PubMed ID: 24850174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.
    Yeo W; Wong N; Wong WL; Lai PB; Zhong S; Johnson PJ
    Liver Int; 2005 Apr; 25(2):266-72. PubMed ID: 15780049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of APC, GSTP1 and SOCS1 promoter methylation with the risk of hepatocellular carcinoma: a meta-analysis.
    Liu M; Cui LH; Li CC; Zhang L
    Eur J Cancer Prev; 2015 Nov; 24(6):470-83. PubMed ID: 25853848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of P14 and MGMT gene methylation in hepatocellular carcinomas: a meta-analysis.
    Li CC; Yu Z; Cui LH; Piao JM; Liu M
    Asian Pac J Cancer Prev; 2014; 15(16):6591-6. PubMed ID: 25169493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal MGMT promoter methylation may contribute to the risk of esophageal cancer: a meta-analysis of cohort studies.
    Zhao JJ; Li HY; Wang D; Yao H; Sun DW
    Tumour Biol; 2014 Oct; 35(10):10085-93. PubMed ID: 25015189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter methylation of DAPK gene may contribute to the pathogenesis of nonsmall cell lung cancer: a meta-analysis.
    Li FF; Yang Y; Wang XL; Hong YY; Wang NF; Chen ZD
    Tumour Biol; 2014 Jun; 35(6):6011-20. PubMed ID: 24659425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma.
    Zhang C; Li J; Huang T; Duan S; Dai D; Jiang D; Sui X; Li D; Chen Y; Ding F; Huang C; Chen G; Wang K
    Oncotarget; 2016 Dec; 7(49):81255-81267. PubMed ID: 27835605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant promoter methylation of the vimentin gene may contribute to colorectal carcinogenesis: a meta-analysis.
    Li YW; Kong FM; Zhou JP; Dong M
    Tumour Biol; 2014 Jul; 35(7):6783-90. PubMed ID: 24729088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of RASSF1A promoter methylation in hepatocellular carcinoma and its prognostic implications.
    Xu B; Di J; Wang Z; Han X; Li Z; Luo X; Zheng Q
    Biochem Biophys Res Commun; 2013 Aug; 438(2):324-8. PubMed ID: 23891693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between promoter methylation in the GSTP1 gene and hepatocellular carcinoma development: a meta-analysis.
    Li QF; Li QY; Gao AR; Shi QF
    Genet Mol Res; 2015 Jun; 14(2):6762-72. PubMed ID: 26125884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant promoter methylation of the SFRP1 gene may contribute to colorectal carcinogenesis: a meta-analysis.
    Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y
    Tumour Biol; 2014 Sep; 35(9):9201-10. PubMed ID: 24929326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RASSF1A promoter hypermethylation as a prognostic marker for hepatocellular carcinoma.
    Saelee P; Wongkham S; Chariyalertsak S; Petmitr S; Chuensumran U
    Asian Pac J Cancer Prev; 2010; 11(6):1677-81. PubMed ID: 21338215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients.
    Araújo OC; Rosa AS; Fernandes A; Niel C; Villela-Nogueira CA; Pannain V; Araujo NM
    PLoS One; 2016; 11(4):e0153796. PubMed ID: 27078152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.